Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 2/20 | 0.46 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.46 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.46 |
| ▸ | KCND3 | Q9UK17 | 1/20 | 0.46 |
| ▸ | PDE4B | Q07343 | 12/20 | 0.40 |
| ▸ | PDE4A | P27815 | 11/20 | 0.40 |
| ▸ | PDE4C | Q08493 | 11/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 11/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7255783 | 0.96 | ABCB1 (0.49) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL4875226 | 0.96 | ABCB1 (0.49) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL4871403 | 0.95 | ABCB1 (0.49) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL4875602 | 0.95 | ABCB1 (0.49) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL4869186 | 0.95 | ABCB1 (0.49) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL4869207 | 0.92 | ABCB1 (0.46) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL4873973 | 0.89 | ABCB1 (0.49) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL4869968 | 0.88 | PDE4B (0.49) | PDE4BPDE4APDE4CPDE4D | |
| SCHEMBL4872609 | 0.88 | ABCB1 (0.52) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL4869453 | 0.88 | PDE4B (0.49) | PDE4BPDE4APDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1086076-B1 | SULFONAMIDE INHIBITORS OF ASPARTYL PROTEASE | VERTEX PHARMA (US) | 2004-12-22 | — | — | EP | disclosed |